WSJ Law Blog: “The big law-and-biz headline from Wednesday involved drug maker GlaxoSmithKline, which agreed to pay $750 million and enter a guilty plea to settle charges that it put bad drugs into the stream of commerce.”
Receive our latest news updates on Twitter, Facebook and your inbox.
Seeger Weiss Announces New Partner and Counsel
Class Plaintiffs Obtain Final Approval of $1.51 Billion Settlement with Syngenta
Seeger Weiss LLP Welcomes Stephan J. Mallenbaum as Executive Director
Statement regarding Judge’s approval of Special Master’s motion to appoint a Special Investigator
NFL Concussion Settlement Claims Exceed $500 million, Surpassing NFL’s Ten-Year Projections in Less Than Two Years